NCT04090567 2026-03-05
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Recruiting
M.D. Anderson Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
Big Ten Cancer Research Consortium
University of Leeds
Mario Negri Institute for Pharmacological Research
IFOM ETS - The AIRC Institute of Molecular Oncology
Institute of Cancer Research, United Kingdom
Seoul National University Hospital